SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?


To: Jon who wrote (11848)2/12/1999 6:50:00 PM
From: David Sirk  Respond to of 25711
 
DD ON HPFS

DD on HPFS
In December, 1991, the Company acquired 100% of Center for Special
Immunology, Inc., a Delaware corporation ("CSI") and its subsidiaries which have
since become the only operating businesses of the Company. CSI owns and
operates an integrated health care delivery and clinical research system that
includes a multi-state network, operating in 9 states, of primary care and
clinical research facilities specializing in immune system disorders, consisting
primarily of HIV, AIDS and Chronic Fatigue Immune Dysfunction Syndrome (CFIDS).
The network also conducts multi-center trials in cooperation with biotechnology
and pharmaceutical companies. CSI was founded in 1986 by William M. Reiter,
M.D., FACP, and Paul J. Cimoch, M.D., FACP, who are both internationally
recognized research physicians. Dr. Reiter is currently Chairman of the Board
and Dr. Cimoch also currently serves on the Board.
edgar-online.com
hivinsite.ucsf.edu

Center for Special Immunology - Irvine, Irvine, CA (714) 753-0670 Cimoch
Center for Special Immunology - San Diego, San Diego, CA (619) 291-1122
Pearce
Center Special Immunology - Chicago, , (312) 296-2400 Berger

yp2.superpages.com

yp1.superpages.com

I called the Number in CHICAGO> The area code has changed but I got Doctor Bergers office. HIV center.

This might not be a scam after all!



To: Jon who wrote (11848)2/12/1999 8:49:00 PM
From: David Sirk  Read Replies (4) | Respond to of 25711
 
Subject 25802